132
Participants
Start Date
October 24, 2018
Primary Completion Date
July 29, 2020
Study Completion Date
September 9, 2020
Q-122
oral capsule of Q-122
Placebo
oral capsule of placebo
Optimal Clinical Trials, Auckland
Auckland City Hospital, Auckland
Women's Health Research Institute of Australia, Sydney
Royal North Shore Hospital, Sydney
School of Public Health and Preventive Medicine, Monash University, Melbourne
The Royal Women's Hospital, Melbourne
P3 Research - Tauranga, Tauranga
ICON Group, Icon Cancer Care Wesley, Brisbane
P3 Research - Hawkes Bay, Havelock North
Royal Adelaide Hospital, Adelaide
Keogh Institute for Medical Research, Perth
Christchurch Clinical Studies Trust Ltd, Christchurch
Stony Brook University, Stony Brook
John Hopkins, Baltimore
North Georgia Clinical Research, Woodstock
Indiana University School of Nursing, Indianapolis
Baylor Scoot & White Medical Center, Temple
Brighams and Women's Hospital, Boston
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
Que Oncology
INDUSTRY